# FLOLAN

NDC: 0173-0519
Generic name: epoprostenol sodium
Labeler / Manufacturer: GlaxoSmithKline LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 19951208
Marketing ended: 20260531
FDA application: NDA020444

## Active ingredients

- EPOPROSTENOL SODIUM: 1.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0173-0519"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0173-0519
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e4b636e-ee9c-4111-779d-28c8369d283b